Global Poliovirus Vaccine Market Insights and Forecast to 2028

Global Poliovirus Vaccine Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Poliovirus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Poliovirus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market by Application
1.3.1 Global Poliovirus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Poliovirus Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Poliovirus Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Poliovirus Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Poliovirus Vaccine Sales by Region
2.4.1 Global Poliovirus Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Poliovirus Vaccine by Region (2023-2028)
2.5 Global Poliovirus Vaccine Revenue by Region
2.5.1 Global Poliovirus Vaccine Revenue by Region (2017-2022)
2.5.2 Global Poliovirus Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Poliovirus Vaccine Sales by Manufacturers
3.1.1 Global Top Poliovirus Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Poliovirus Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Poliovirus Vaccine in 2021
3.2 Global Poliovirus Vaccine Revenue by Manufacturers
3.2.1 Global Poliovirus Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Poliovirus Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Poliovirus Vaccine Revenue in 2021
3.3 Global Poliovirus Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Poliovirus Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Poliovirus Vaccine Sales by Type
4.1.1 Global Poliovirus Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Poliovirus Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Poliovirus Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Poliovirus Vaccine Revenue by Type
4.2.1 Global Poliovirus Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Poliovirus Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Poliovirus Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Poliovirus Vaccine Price by Type
4.3.1 Global Poliovirus Vaccine Price by Type (2017-2022)
4.3.2 Global Poliovirus Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Poliovirus Vaccine Sales by Application
5.1.1 Global Poliovirus Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Poliovirus Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Poliovirus Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Poliovirus Vaccine Revenue by Application
5.2.1 Global Poliovirus Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Poliovirus Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Poliovirus Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Poliovirus Vaccine Price by Application
5.3.1 Global Poliovirus Vaccine Price by Application (2017-2022)
5.3.2 Global Poliovirus Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Poliovirus Vaccine Market Size by Type
6.1.1 North America Poliovirus Vaccine Sales by Type (2017-2028)
6.1.2 North America Poliovirus Vaccine Revenue by Type (2017-2028)
6.2 North America Poliovirus Vaccine Market Size by Application
6.2.1 North America Poliovirus Vaccine Sales by Application (2017-2028)
6.2.2 North America Poliovirus Vaccine Revenue by Application (2017-2028)
6.3 North America Poliovirus Vaccine Market Size by Country
6.3.1 North America Poliovirus Vaccine Sales by Country (2017-2028)
6.3.2 North America Poliovirus Vaccine Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Poliovirus Vaccine Market Size by Type
7.1.1 Europe Poliovirus Vaccine Sales by Type (2017-2028)
7.1.2 Europe Poliovirus Vaccine Revenue by Type (2017-2028)
7.2 Europe Poliovirus Vaccine Market Size by Application
7.2.1 Europe Poliovirus Vaccine Sales by Application (2017-2028)
7.2.2 Europe Poliovirus Vaccine Revenue by Application (2017-2028)
7.3 Europe Poliovirus Vaccine Market Size by Country
7.3.1 Europe Poliovirus Vaccine Sales by Country (2017-2028)
7.3.2 Europe Poliovirus Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Poliovirus Vaccine Market Size by Type
8.1.1 Asia Pacific Poliovirus Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Poliovirus Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Poliovirus Vaccine Market Size by Application
8.2.1 Asia Pacific Poliovirus Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Poliovirus Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Poliovirus Vaccine Market Size by Region
8.3.1 Asia Pacific Poliovirus Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Poliovirus Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Poliovirus Vaccine Market Size by Type
9.1.1 Latin America Poliovirus Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Poliovirus Vaccine Revenue by Type (2017-2028)
9.2 Latin America Poliovirus Vaccine Market Size by Application
9.2.1 Latin America Poliovirus Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Poliovirus Vaccine Revenue by Application (2017-2028)
9.3 Latin America Poliovirus Vaccine Market Size by Country
9.3.1 Latin America Poliovirus Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Poliovirus Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Poliovirus Vaccine Market Size by Type
10.1.1 Middle East and Africa Poliovirus Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Poliovirus Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Poliovirus Vaccine Market Size by Application
10.2.1 Middle East and Africa Poliovirus Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Poliovirus Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Poliovirus Vaccine Market Size by Country
10.3.1 Middle East and Africa Poliovirus Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Poliovirus Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Bibcol
11.3.1 Bibcol Corporation Information
11.3.2 Bibcol Overview
11.3.3 Bibcol Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bibcol Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bibcol Recent Developments
11.4 Serum Institute
11.4.1 Serum Institute Corporation Information
11.4.2 Serum Institute Overview
11.4.3 Serum Institute Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Serum Institute Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Serum Institute Recent Developments
11.5 Tiantan Biological
11.5.1 Tiantan Biological Corporation Information
11.5.2 Tiantan Biological Overview
11.5.3 Tiantan Biological Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Tiantan Biological Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Tiantan Biological Recent Developments
11.6 IMBCA
11.6.1 IMBCA Corporation Information
11.6.2 IMBCA Overview
11.6.3 IMBCA Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 IMBCA Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 IMBCA Recent Developments
11.7 Panacea Biotec Ltd
11.7.1 Panacea Biotec Ltd Corporation Information
11.7.2 Panacea Biotec Ltd Overview
11.7.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Panacea Biotec Ltd Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Panacea Biotec Ltd Recent Developments
11.8 Bio-Med
11.8.1 Bio-Med Corporation Information
11.8.2 Bio-Med Overview
11.8.3 Bio-Med Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bio-Med Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio-Med Recent Developments
11.9 Halfkin Bio-Pharmaceuticals
11.9.1 Halfkin Bio-Pharmaceuticals Corporation Information
11.9.2 Halfkin Bio-Pharmaceuticals Overview
11.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Halfkin Bio-Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Poliovirus Vaccine Industry Chain Analysis
12.2 Poliovirus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Poliovirus Vaccine Production Mode & Process
12.4 Poliovirus Vaccine Sales and Marketing
12.4.1 Poliovirus Vaccine Sales Channels
12.4.2 Poliovirus Vaccine Distributors
12.5 Poliovirus Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Poliovirus Vaccine Industry Trends
13.2 Poliovirus Vaccine Market Drivers
13.3 Poliovirus Vaccine Market Challenges
13.4 Poliovirus Vaccine Market Restraints
14 Key Findings in The Global Poliovirus Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Poliovirus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Inactivated Polio Vaccine (IPV)
Table 3. Major Manufacturers of Oral Polio Vaccine (OPV)
Table 4. Global Poliovirus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Poliovirus Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 7. Global Poliovirus Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 9. Global Poliovirus Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Poliovirus Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Poliovirus Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Poliovirus Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Poliovirus Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Poliovirus Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Poliovirus Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Poliovirus Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Poliovirus Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Poliovirus Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Poliovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Poliovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2021)
Table 21. Poliovirus Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Poliovirus Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Poliovirus Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 26. Global Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 27. Global Poliovirus Vaccine Sales Share by Type (2017-2022)
Table 28. Global Poliovirus Vaccine Sales Share by Type (2023-2028)
Table 29. Global Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Poliovirus Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Poliovirus Vaccine Revenue Share by Type (2023-2028)
Table 33. Poliovirus Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Poliovirus Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 36. Global Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 37. Global Poliovirus Vaccine Sales Share by Application (2017-2022)
Table 38. Global Poliovirus Vaccine Sales Share by Application (2023-2028)
Table 39. Global Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Poliovirus Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Poliovirus Vaccine Revenue Share by Application (2023-2028)
Table 43. Poliovirus Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Poliovirus Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. North America Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 47. North America Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. North America Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 51. North America Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 54. North America Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 55. North America Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Poliovirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Poliovirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Poliovirus Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Poliovirus Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Poliovirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Poliovirus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Major Businesses
Table 107. Sanofi Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Sanofi Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Sanofi Recent Developments
Table 110. GSK Corporation Information
Table 111. GSK Description and Major Businesses
Table 112. GSK Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. GSK Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. GSK Recent Developments
Table 115. Bibcol Corporation Information
Table 116. Bibcol Description and Major Businesses
Table 117. Bibcol Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Bibcol Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bibcol Recent Developments
Table 120. Serum Institute Corporation Information
Table 121. Serum Institute Description and Major Businesses
Table 122. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Serum Institute Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Serum Institute Recent Developments
Table 125. Tiantan Biological Corporation Information
Table 126. Tiantan Biological Description and Major Businesses
Table 127. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Tiantan Biological Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Tiantan Biological Recent Developments
Table 130. IMBCA Corporation Information
Table 131. IMBCA Description and Major Businesses
Table 132. IMBCA Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. IMBCA Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. IMBCA Recent Developments
Table 135. Panacea Biotec Ltd Corporation Information
Table 136. Panacea Biotec Ltd Description and Major Businesses
Table 137. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Panacea Biotec Ltd Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Panacea Biotec Ltd Recent Developments
Table 140. Bio-Med Corporation Information
Table 141. Bio-Med Description and Major Businesses
Table 142. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Bio-Med Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Bio-Med Recent Developments
Table 145. Halfkin Bio-Pharmaceuticals Corporation Information
Table 146. Halfkin Bio-Pharmaceuticals Description and Major Businesses
Table 147. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 148. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Halfkin Bio-Pharmaceuticals Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Poliovirus Vaccine Distributors List
Table 153. Poliovirus Vaccine Customers List
Table 154. Poliovirus Vaccine Market Trends
Table 155. Poliovirus Vaccine Market Drivers
Table 156. Poliovirus Vaccine Market Challenges
Table 157. Poliovirus Vaccine Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Poliovirus Vaccine Product Picture
Figure 3. Global Poliovirus Vaccine Market Share by Type in 2021 & 2028
Figure 3. Inactivated Polio Vaccine (IPV) Product Picture
Figure 4. Oral Polio Vaccine (OPV) Product Picture
Figure 5. Global Poliovirus Vaccine Market Share by Application in 2021 & 2028
Figure 6. Public
Figure 7. Private
Figure 8. Poliovirus Vaccine Report Years Considered
Figure 9. Global Poliovirus Vaccine Sales 2017-2028 (K Units)
Figure 10. Global Poliovirus Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Poliovirus Vaccine Revenue 2017-2028 (US$ Million)
Figure 12. Global Poliovirus Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Poliovirus Vaccine Sales Market Share by Region (2017-2022)
Figure 14. Global Poliovirus Vaccine Sales Market Share by Region (2023-2028)
Figure 15. North America Poliovirus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 16. North America Poliovirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Poliovirus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Poliovirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Poliovirus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Poliovirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Poliovirus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Poliovirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Poliovirus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Poliovirus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Poliovirus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Poliovirus Vaccine in the World: Market Share by Poliovirus Vaccine Revenue in 2021
Figure 27. Global Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 29. Global Poliovirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 30. Global Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 31. Global Poliovirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 32. North America Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 33. North America Poliovirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 34. North America Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 35. North America Poliovirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 36. North America Poliovirus Vaccine Sales Share by Country (2017-2028)
Figure 37. North America Poliovirus Vaccine Revenue Share by Country (2017-2028)
Figure 38. the United States Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 41. Europe Poliovirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 43. Europe Poliovirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Poliovirus Vaccine Sales Share by Country (2017-2028)
Figure 45. Europe Poliovirus Vaccine Revenue Share by Country (2017-2028)
Figure 46. Germany Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 47. France Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. UK Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Poliovirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Poliovirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Poliovirus Vaccine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Poliovirus Vaccine Revenue Share by Region (2017-2028)
Figure 57. China Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. India Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 67. Latin America Poliovirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Latin America Poliovirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Poliovirus Vaccine Sales Share by Country (2017-2028)
Figure 71. Latin America Poliovirus Vaccine Revenue Share by Country (2017-2028)
Figure 72. Mexico Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Poliovirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Poliovirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Poliovirus Vaccine Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Poliovirus Vaccine Revenue Share by Country (2017-2028)
Figure 81. Turkey Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Poliovirus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Poliovirus Vaccine Revenue (2017-2028) & (US$ M

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs